Trial results for a study assessing the usability of the MeTime MS App in adults with Multiple Sclerosis were posted on 2025-11-20, revealing a mean System Usability Scale (SUS) score of 35.8 for the relaxing self-acupressure protocol.

Background

Multiple Sclerosis (MS) is a chronic, often debilitating disease that affects the brain and spinal cord. Patients with MS frequently experience symptoms such as pain and fatigue, which can significantly impact their quality of life. Self-management strategies, including non-pharmacological approaches like acupressure, are explored to help individuals manage these symptoms. Digital health applications offer a potential avenue for delivering such interventions, enabling self-administration and personalized support. The MeTime MS App was developed to facilitate self-administration of acupressure, offering both "relaxing" and "stimulating" protocols.

Trial design

This completed study, identified as Phase NA, enrolled 10 adult participants with Multiple Sclerosis, who also experienced Pain and Fatigue Symptom. The primary objective of the study was to assess the usability of the MeTime MS app. The app delivers two forms of self-acupressure protocols: a "relaxing" protocol and a "stimulating" protocol.

Key results

The trial reported on participant perception of the MeTime MS App's usability and System Usability Scale (SUS) scores:

The System Usability Scale (SUS) adapted for the MeTime MS App provided quantitative usability metrics:

What this means

The posted results provide initial insights into the usability of the MeTime MS App for individuals with Multiple Sclerosis, pain, and fatigue. The System Usability Scale (SUS) scores offer a quantitative measure of perceived usability, with the relaxing self-acupressure protocol achieving a mean score of 35.8 and the stimulating protocol a mean score of 29.5. These scores, alongside the qualitative participant comments, contribute to understanding user experience with the app. This information is valuable for informing further development and refinement of the MeTime MS App as a self-management tool for MS-related symptoms.

Source

The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT07123272, titled "Usability of the MeTime MS App", were posted on 2025-11-20 on clinicaltrials.gov.